Four and A Half LIM Domains 3 (FHL3) Peptide
Quick Overview for Four and A Half LIM Domains 3 (FHL3) Peptide (ABIN939223)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- HRECLVCTGC QTPLAGQQFT SRDEDPYCVA CFGELFAPKC SSCKRPIVGL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FHL3 antibody,
Alternative Names: FHL3 control peptide, FHL3 antibody Blocking Peptide, Anti-FHL3 Blocking Peptide, four and a half LIM domains 3 Blocking Peptide, MGC19547 Blocking Peptide, MGC23614 Blocking Peptide, MGC8696 Blocking Peptide, SLIM2 Blocking Peptide, FHL3, FHL-3, FHL 3, FHL-3 Blocking Peptide, FHL 3 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- FHL3 (Four and A Half LIM Domains 3 (FHL3))
-
Background
- FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.
-
Molecular Weight
- 31 kDa
Target
-